| Friday, January 10, 2025 |
| 01:30 PM - 06:00 PM China Standard Time |
EY will host an event to review the compliance milestones of the pharmaceutical industry in 2024 and look forward to the compliance trends in 2025. Litigation partner Bingna Guo will speak on the panel Compliance Trend and Outlook at this meeting. Since 2023, the supervision of the domestic medical field in China has been unprecedented.
The ministries and commissions of the state have worked with the discipline inspection and supervision agencies to carry out a nationwide concentrated rectification of problems in the medical field. The health commissions of various provinces and cities have actively followed up and deployed, and the key points and directions of law enforcement have become more detailed. The policy density and attention in the field of anti-commercial bribery compliance has also been greatly improved.
For more information or to register, please contact Summer Zhu.